EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
EMVO
EAHP joined the European Medicines Verification Organisation (EMVO) before the GA as affiliate member. EMVO has 5 full members (EFPIA (The European Federation of Pharmaceutical Industries and Associations), Medicines for Europe (The European Generic and Biosimilar Medicines Association), PGEU (The Pharmaceutical Group of the European Union), GIRP (The European Healthcare Distribution Association) and EAEPC (The European Association of Euro-Pharmaceutical Companies)) and one other affiliate member (HOPE – European Hospital and Healthcare Federation). The different stakeholders meet monthly during the so-called “Stakeholder meetings” and at the board meetings which occur 4 times per year. In addition, EMVO organizes meetings for the project managers of the National Medicines Verification Organisations (NMVOs) as well as workshops for its different working groups, while EFPIA and Medicines for Europe organize meetings for the different marketing authorisation holders. EMVO stakeholders are encouraged to attend these meetings.
The different meetings for 2017 known to us are listed HERE
The list changes continuously since EMVO frequently moves meeting dates/ adds new meetings.
Between June and mid-September 2017, EAHP attended the following EMVO meetings:
The meetings that were attended by us where on the one hand useful to understand the dynamics within EMVO and to get up to speed on what has been discussed by the different stakeholders earlier this year. However, on the other hand the meetings tend to repeat information, since the different stakeholders usually “highjack” the agenda to discuss problems that they have with each other (i.e. industry fighting with PGEU/GIRP over trust among stakeholders or Medicines for Europe fighting with Andreas Walter over the fact that the position paper on blueprint is not further perused).
In addition, to the different meetings Andreas Walter circulates a lot of information (i.e. emails between him and NVMOs – particularly in cases in which NMVOs don’t want to follow his instructions) with stakeholders for transparency reasons.
Hospital Pharmacy Platform
Prior to the discussions about the hospital platform we conducted a small survey inviting our members to provide input on the current FMD situation in their country. Not all members affected by FMD (i.e. EU Member States, EEA and Switzerland) participated, but we still received feedback from 19 countries. The survey focused on 4 different areas – NMVO involvement; government entity involvement, stakeholder support and requests/suggestions for EAHP. The results are available HERE
HOPE produced a similar document by requesting input from its members HERE
The information collected by both EAHP and HOPE will be shared with platform participants in order to minimise the time that is spent during the face-to-face meeting on national issues.
At the meeting between HOPE, EAHP and EMVO, Andreas Walter brought forward the idea to create a hospital platform that both EAHP and HOPE could use to share experiences and ideas for the implementation of the FMD in hospitals. We took this idea and discussed it at the beginning of July during a meeting between HOPE and EAHP. During the meeting it was determined that both EAHP and HOPE will seek experts on the topic. The criteria discussed during the meeting suggested the participation of 1 expert per country, the limitation of the group to 10 members, an equal distribution of participants from different regions as well as an equal distribution between EAHP and HOPE members. It was decided to hold the kick-off face-to-face meeting of the hospital platform on 26th September. During this meeting we want to determine the functioning of the platform.
After our discussions with HOPE, Andreas Walter reviled to us that the other EMVO Stakeholders were not aware of our “project” and thus needed to be briefed by us on the intentions of the platform. For transparency reasons he also urged us to invite all EMVO Stakeholders to the meeting of the platform. This bit of information was news to both us and HOPE, since we were under the impression that Andreas had discussed his ideas for the hospital platform with the other stakeholders prior to suggesting it to us. Since EMVO is travelling on 26th September, Andreas requested to change the meeting date. We decided not to comply with his request, since the meeting should only involve EAHP and HOPE. Input from EMVO stakeholders could be possible at a later stage but not from the very start. Andreas was not particularly happy with our response and thus will discuss the issue with all stakeholders (including HOPE and us) during the upcoming EMVO board meeting on 19th September. András will attend this meeting.
Moreover, the following persons will participate in the hospital platform:
In addition, Pascal Garel and Valentina Lisi (HOPE Office) will be present at the meeting. András and I will join from EAHP’s side. Pascal’s reason for inviting to persons from the UK and Germany – contrary to the agreement reached during our initial discussion – is that one has more political knowledge while the other has more technical knowledge.
Requests by GIRP – Meeting to discuss cooperation
GIRP (European Healthcare Distribution Association) would be interested in meeting with us to discuss how its members could assist hospital pharmacies to meet their obligations with the Falsified Medicines Directive and the Delegated Regulation. They sent the cooperation request together with an invitation to speak at their conference. Rob will be speaking at their autumn meeting in November on facilitating compliance for hospital pharmacies.
It needs to be discussed if EAHP should meet with GIRP to discuss cooperation opportunities for FMD.
